Medical Management of Infants With Supraventricular Tachycardia: Results From a Registry and Review of the Literature-Reference-Cited by-同舟云学术

Medical Management of Infants With Supraventricular Tachycardia: Results From a Registry and Review of the Literature

Published:2022-02 Issue:1 Volume:1 Page:11-22
ISSN:2772-8129
Container-title:CJC Pediatric and Congenital Heart Disease
language:en
Short-container-title:CJC Pediatric and Congenital Heart Disease

Author:

Wei Nathan,Lamba Avani,Franciosi Sonia,Law Ian H.,Ochoa Luis A.,Johnsrude Christopher L.,Kwok Sit Yee,Tan Teng Hong,Dhillon Santokh S.,Fournier Anne,Seslar Stephen P.,Stephenson Elizabeth A.,Blaufox Andrew D.,Ortega Michel Cabrera,Bone Jeffrey N.,Sandhu Ash,Escudero Carolina A.,Sanatani Shubhayan

Publisher

Elsevier BV

Reference38 articles.

1. Adenosine in the emergency management of supraventricular tachycardia;Ros;Pediatr Emerg Care,1991

2. Adenosine in the treatment of paroxysmal supraventricular tachycardia in children;Reyes;Ann Emerg Med,1992

3. Is the mechanism of supraventricular tachycardia in pediatrics influenced by age, gender or ethnicity?;Anand;Congenit Heart Dis,2009

4. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients;Ko;Am J Cardiol,1992

5. Pediatric dysrhythmias;Doniger;Pediatr Clin North Am,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiarrhythmic therapy for narrow QRS supraventricular tachyarrhythmias in newborns and infants in the first year of life: Potent tools to be handled with care;Indian Pacing and Electrophysiology Journal;2024-07

2. Evaluating antiarrhythmic drugs for managing infants with supraventricular tachycardia; a review;American Journal of Cardiovascular Disease;2024

3. Acute Arrhythmia Management Protocol;Manual of Pediatric Cardiac Care;2024

4. Outcomes in Infants with Supraventricular Tachycardia: Risk Factors for Readmission, Recurrence and Ablation;Pediatric Cardiology;2022-10-22

5. CJC Pediatric and Congenital Heart Disease: The Next Frontier;CJC Pediatric and Congenital Heart Disease;2022-02